Short answer
Short answer: barely, and not for the reason they are sold. The Cochrane review of blue-light filtering spectacle lenses graded the sleep evidence very low certainty — of six studies looking at sleep, three found an improvement and three found none. What is well established is a different claim: light at night suppresses melatonin and shifts body-clock timing. "Amber lenses in front of a screen improve your sleep" is not the same statement, and it has nowhere near the same support.
EIVOI does not sell blue light glasses. Nothing here earns us anything. We sell a sleep mask and a white noise machine, so we are not disinterested in sleep generally — we just have no product in this fight, which is why we can answer plainly.
Two claims get welded together, and only one holds
Every listing runs the same argument: blue light suppresses melatonin, melatonin governs sleep, therefore blocking blue light improves sleep. The first step is solid. The last is where it fails.
Gooley and colleagues, in the Journal of Clinical Endocrinology and Metabolism in 2011, exposed 116 healthy volunteers to ordinary room light before bed and found it shortened the nightly window of melatonin production by roughly ninety minutes compared with dim light. Phillips, Vidafar, Cain and colleagues, in PNAS in 2019, found individuals differ by more than fifty-fold in the light needed to halve their melatonin — something no lens and no product page can tell you about a particular person.
Brown, Brainard, Czeisler, Lockley, Wright and a large expert panel turned that into guidance in PLOS Biology in March 2022: at most 10 lux melanopic EDI at eye level in the three hours before bed, around 1 lux while asleep. That is advice about how much light reaches your eyes and when, not about filtering part of it.
What the Cochrane review concluded
The reference point is Singh, Keller, Busija, McMillan, Makrai, Lawrenson, Hull and Downie, published by Cochrane on 18 August 2023: 17 randomised trials, 619 participants, six countries. On eye strain it concluded the lenses may make no difference in the short term. On sleep, six studies covering 148 participants split evenly — three improvements, three nulls — graded very low certainty, the lowest rung available. Author Professor John Lawrenson said the findings reinforced existing optometry position statements on the lack of evidence for these lenses; the American Academy of Ophthalmology does not recommend them either, attributing screen discomfort to how screens are used rather than to the light. Lead author Dr Sumeer Singh noted that screens give the eye roughly a thousandth of the light daylight does, and that these lenses typically filter 10 to 25 per cent of blue light.
Lens colour is the variable almost no listing states
"Blue light glasses" is not a specification. It covers everything from a nearly clear lens with a faint coating to a deep amber or red one, and they filter very different amounts.
Alzahrani, Khuu and Roy, in Clinical and Experimental Optometry in 2019, measured seven commercial blue-blocking lens types from six manufacturers: reductions of 6 to 43 per cent across 400–500 nm, falling to 4 to 27 per cent once weighted for the circadian-relevant response. Glickman, Harrison, Herf, Herf and Brown, in Translational Vision Science and Technology in July 2025, proposed a standardised measure — melanopic daylight filtering density — applied it to 26 commercial products, and concluded only those at the stronger end meaningfully reduced melanopic input, with timing and consistency of wear mattering as much as the lens itself.
So a clear or lightly tinted lens is very unlikely to move your melatonin; a properly amber or red one plausibly can. If a listing will not say what proportion it removes, and at which wavelengths, treat it as an accessory with a health story.
The positive findings, and why they are not enough
Burkhart and Phelps, in Chronobiology International in 2009, randomised 20 adults to amber lenses blocking below 550 nm or to controls for three hours before bed, and found better self-reported sleep quality and mood in the amber group, though baseline differences limit the finding. Shechter, Kim, St-Onge and Westwood, in the Journal of Psychiatric Research in 2018, gave 14 people with insomnia amber versus clear placebo glasses in a crossover trial and reported about thirty minutes more sleep on amber weeks. Shechter's group's review in SLEEP Advances in 2020 covered 12 studies: a large effect on the self-reported Pittsburgh Sleep Quality Index, a small one on measured total sleep time, eight positive and four null — on samples of six to twenty-one people, half not describing randomisation properly, with the clearest benefits in clinical groups.
Against that, Luna-Rangel, Gonzalez-Bedolla, Salazar-Ortega, Torres-Mancilla and Martinez-Cadena, in Frontiers in Neurology on 18 November 2025, pooled three double-blind crossover trials using actigraphy — amber lenses against indistinguishable clear controls, 49 participants — and found no significant effect on sleep onset latency, total sleep time, sleep efficiency or time awake.
Effects look best in small unblinded studies using questionnaires and shrink to nothing once controls are indistinguishable and outcomes measured — the same pattern as in the evidence behind white noise machines, a product we do sell.
It may not be the light at all
The most awkward finding here has nothing to do with lenses. The National Sleep Foundation's consensus statement on screens and sleep, in Sleep Health on 28 May 2024, agreed that the content of screen use before sleep impairs sleep health in children and adolescents. On whether screen light has a direct effect the panel could not reach consensus — panellist Lauren Hartstein put it as the data not being strong enough to say so conclusively — and it reached no consensus that screens affect adult sleep at all. If what keeps you up is an argument in a comment thread at 11pm, amber lenses change nothing.